Axcelis Technologies is a leading supplier of ion implantation equipment used in semiconductor manufacturing, a market closely tied to power semiconductors, memory, and mature-node chips. Its quarterly results offer investors a read on capital spending across these cyclical end markets. Heading into the report, the company had been recovering from a period of customer capacity digestion, and analysts were watching whether improving order trends would translate into sustained growth. The third-quarter release matters because it tests management's thesis that demand is firming across power and memory, while also providing a window into profitability amid currency headwinds and an anticipated merger with Veeco Instruments. From what I see, this kind of data helps clarify whether the recovery story is holding up.
For the third quarter of 2026, Axcelis Technologies reported total revenue of $238 million, exceeding the Zacks Consensus Estimate and rising from $213.6 million in the prior-year period. Diluted non-GAAP EPS came in at $1.26, well above management's guidance of $1.11 and ahead of the consensus estimate of $1.11, representing an earnings surprise of more than 13%. I also checked this using Tickeron’s AI Screener to compare the results against peers in the semiconductor equipment space.
Gross margin was 41.2%, below the company's approximately 43% outlook, which management attributed primarily to the sharp strengthening of the Korean won relative to the U.S. dollar. Operating expenses of $58.5 million came in below the $62 million outlook, and operating margin reached 16.6%. Adjusted EBITDA was $44 million, an 18.5% margin. Free cash flow totaled $38 million, and the company ended the quarter with $615 million in cash equivalents and marketable securities.
Bookings were the quarter's standout metric, rising to $222 million—the highest level since the fourth quarter of 2023—with a book-to-bill ratio of 1.5x. Backlog increased to $531 million. China remained the largest revenue region at 46% of total sales, followed by Korea at 18%.
The third-quarter results were generally well received, with the earnings and revenue beats plus the sharp rebound in bookings reinforcing the narrative of a strengthening demand backdrop. ACLS shares have added roughly 14.7% since the start of the year, outpacing the S&P 500's gain over the same stretch, reflecting investor optimism around improving order momentum and the pending Veeco combination.
Still, the quarter highlighted a key sensitivity: the strengthening Korean won weighed on gross margin, a reminder that currency moves can offset otherwise solid operational execution. Investors appeared to weigh these margin headwinds against the encouraging forward guidance and record-level bookings as they assessed the company's trajectory into 2027.
Axcelis provided a notably stronger fourth-quarter outlook, guiding to revenue of approximately $275 million, gross margin of about 42.5%, adjusted EBITDA of roughly $56 million, and diluted EPS of approximately $1.50. Management also indicated that first-quarter 2027 revenue is expected to be relatively consistent with fourth-quarter levels, despite typically softer seasonal aftermarket activity.
Several factors will be worth watching in the coming quarters. First, the pending merger with Veeco Instruments remains a central catalyst, with closing subject to regulatory approvals, including in China. Second, currency exposure—particularly the Korean won—will continue to influence margins given Axcelis's growing presence in Korea. Investors should also monitor bookings and the book-to-bill ratio for evidence that the recent demand rebound is durable rather than a one-quarter spike. Trends in power semiconductors, memory, and general mature-node demand will shape the revenue trajectory, while cost discipline and gross-margin recovery will determine whether the stronger top line translates into sustained profitability. One thing that stands out is how the book-to-bill metric could signal durability here.
In my ongoing analysis of semiconductor equipment names, I regularly turn to Tickeron’s AI Screener to filter for technical patterns, fundamentals, and industry trends. It helps surface comparable ideas more efficiently than manual reviews, especially when evaluating names like ACLS against peers during earnings season. This kind of structured scanning supports a clearer view of relative positioning without replacing core fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ACLS moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 27 of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACLS as a result. In 67 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for ACLS turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 40 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
The 10-day moving average for ACLS crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
The 50-day moving average for ACLS moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for ACLS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ACLS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +4.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACLS advanced for three days, in 258 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
ACLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.670) is normal, around the industry mean (6.097). P/E Ratio (30.713) is within average values for comparable stocks, (79.345). Projected Growth (PEG Ratio) (0.330) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.733) is also within normal values, averaging (27.897).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ACLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of semiconductor equipment
Industry ElectronicProductionEquipment